3 Mins Read Cellular agriculture biotech 108Labs is developing “whole-human infant formula” that contains the biosimilar secretory antimicrobial antibodies from mother’s milk. The discovery, made during the development of its patent-pending Colostrupedics formula, could provide newborns with protection against gastrointestinal pathogens, putting 108Labs’ cell-based solution at the forefront of disrupting the infant nutrition market.  108Labs, the U.S.-based biotech […]

The post 108Labs To Launch Cell-Based ‘Whole-Human Infant Formula’ With Antibodies Against Pathogens appeared first on Green Queen.

This post was originally published on Green Queen.